MUC1 and pancreatic neoplasm: To study the protective immune response of pcDNA3.1-VNTR vaccine against pancreatic cancer, the mice were inoculated with pcDNA3.1-VNTR three times before the mice were challenged with 1 × 106panc02-MUC1 or panc02.